Navigation Links
China Medical Technologies Adjusts Conversion Rate of Convertible Notes
Date:7/25/2008

BEIJING, July 25 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy systems, today announced adjustment to conversion rate for the Company's US$150 million outstanding 3.5% Convertible Senior Subordinated Notes due November 2011 (the ''Convertible Notes'').

Conversion rate of the Convertible Notes is adjusted from 31.3953 American Depositary Shares (''ADSs'') to 31.7378 ADSs for each US$1,000 original principal amount of the Convertible Notes with reference to the closing market price of the Company's ADSs on July 24, 2008. The resulting conversion price for the Convertible Notes is reduced from US$31.85 to US$31.51. The adjustment is effective immediately prior to the opening of business on July 25, 2008, Eastern Time. The adjustment is required, in accordance with the terms of the indenture governing the Convertible Notes, as a result of the Company's declaration of cash dividend of US$0.05 per share, equivalent to US$0.50 per ADS. Assuming full conversion of the Convertible Notes, additional 513,750 ordinary shares, equivalent to 51,375 ADSs will be issued by the Company as a result of the adjustment to conversion rate.

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostics products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and system using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For more information, please visit http://www.chinameditech.com .

For more information, please contact:

Winnie Yam

Tel: +86-10-6530-8833

Email: IR@chinameditech.com


'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Files Application for Nasdaq Listing
2. China Biologic Products Honored with the Advanced Technology Certification for Foreign-Funded Enterprises
3. China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008
4. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
5. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
6. China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province
7. China Agritech to Export Products to Egypt
8. China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 2008
9. China Pharma Holdings, Inc. to Present at Collins Stewart Fourth Annual Growth Conference in New York on July 8, 2008 at 2:00 p.m. EDT
10. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
11. China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County, Guangxi Province
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Scientists at ... line options being tried for mesothelioma may be hampering the research that could lead ... research. Click here to read it now. , The team evaluated 98 ...
(Date:5/24/2016)... ... 24, 2016 , ... Cell therapies for a range of ... research at Worcester Polytechnic Institute (WPI) that yielded a newly patented method of ... The novel method, developed by WPI faculty members Raymond Page, PhD, professor of ...
(Date:5/23/2016)... ... May 23, 2016 , ... The need for blood donations in South Texas and across ... South Texas Blood & Tissue Center, blood donations are on the decline. In fact, donations ... are down 21 percent in South Texas in the last four years alone. , There ...
(Date:5/23/2016)... and LONDON , May 23, 2016 ... Frontage Boost Efficiency by 40% - Frontage Implement a ... Frontage Enforce Quality, Compliance and Traceability Within the Bioanalytical lab ... in the United States and ... be deployed across its laboratory facilities. In addition to serving as ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
Breaking Biology News(10 mins):